Sarepta Therapeutics, Inc.
Develops precision genetic medicines for rare neuromuscular disorders.
SRPT | US
Overview
Corporate Details
- ISIN(s):
- US8036071004
- LEI:
- Country:
- United States of America
- Address:
- 215 FIRST STREET, 2142 CAMBRIDGE
- Website:
- https://www.sarepta.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Sarepta Therapeutics, Inc. is a global biotechnology company focused on engineering precision genetic medicines to treat rare diseases. The company's primary mission is to develop therapies for conditions with few or no treatment options, with a significant focus on neuromuscular disorders like Duchenne muscular dystrophy, limb-girdle muscular dystrophy, and Charcot-Marie-Tooth disease. Sarepta utilizes advanced scientific platforms, including RNA-targeted technologies, gene therapy, and gene editing. It has multiple FDA-approved treatments and maintains a pipeline of over 40 programs. The company is also focused on accelerating drug development timelines and building large-scale gene therapy manufacturing capacity to support patient access.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Sarepta Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sarepta Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sarepta Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
